New Concepts in IBD Pathology Xianyong (Sean) Gui, MD Associate Professor, Anatomic Pathology Department of Laboratory Medicine & Pathology University of Washington Objectives: - Identify the major histopathologic features of ulcerative colitis and Crohn’s disease and the various types of precancerous mucosal lesions associated with IBD
- Recognize the current role and challenge of histopathology in clinical diagnosis and management of IBD
- Discuss the basic pathogenetic mechanisms of IBD and some to-be-understood questions related to IBD pathology
Speaker disclosures: Dr. Xianyong Gui has NOT had any financial relationships with any ineligible entities within the past 24 months. Why Attend? Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic, idiopathic, debilitating, and currently incurable inflammatory disorder of gut. It is an increasing global burden. Histopathology plays a critical role in IBD medicine, including establishing diagnosis, evaluating disease activity, monitoring medical treatment effect, assessing mucosal healing status, predicting relapse risk, and detecting neoplastic development in patients with longstanding disease. In this presentation, Dr. Gui will describe the updates in pathological concepts of IBD and IBD-associated colorectal neoplasia, discuss the current and evolving roles and challenges of histopathology in clinical management of IBD, and highlight the latest knowledge about the pathogenesis of IBD. Meeting ID: 931 1873 4050 Passcode: PGR2122You must sign-in on the following form to receive CME credit. Sign-in online: https://forms.gle/W2oE8d3MYbnyTDe58 Planning Committee Disclosure: The following members have not had any financial relationships with any ineligible entities in the past 24 months: Drs. Rebecca Alvarez, Eleanor Chen, Lisa Koch, Jose Mantilla, Elizabeth Parker, Maria Tretiakova, Larry True, James Malleis, and Trent Irwin. The following members disclose financial relations with ineligible entities within the past 24 months: Dr Shreeram Akilesh discloses a financial relationship (speaker honorarium) with GoldfinchBio, Inc.; Dr. Haodong Xu discloses a financial relationship with PathomIQ (consultant). All relevant financial relationships listed have been mitigated. Grant Acknowledgment: None
CME Accreditation statement: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Washington School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit) |